Search Within

Isabelle C Riviere

Formats
  1. Meeting Abstract (140)
  2. Journal Article (94)
  3. Book Section (2)
  4. Conference Paper (2)
  5. Review (2)
  6. Editorial (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (242)
  3. GSK Faculty (221)
  4. Center for Hematologic Malignancies (218)
  5. Hematologic Malignancies Research (214)
  6. Sloan Kettering Institute Faculty (208)

More Groups

People
  1. Michel Sadelain (201)
  2. Xiuyan Wang (113)
  3. Renier Brentjens (111)
  4. Jae Park (85)
  5. Brigitte Senechal (42)
  6. Kevin Curran (41)

More People

Years
  1. 2025 (3)
  2. 2024 (1)
  3. 2023 (11)
  4. 2022 (13)
  5. 2021 (13)
  6. 2020 (8)

More Years

Publications
  1. Blood (56)
  2. Molecular Therapy (42)
  3. Journal of Clinical Oncology (21)
  4. Human Gene Therapy (10)
  5. Cancer Research (8)
  6. Haematologica (6)

More Publications

Publishers
  1. Nature Publishing Group (67)
  2. American Society of Hematology (57)
  3. American Society of Clinical Oncology (22)
  4. American Association for Cancer Research (15)
  5. Elsevier Inc. (14)
  6. Mary Ann Liebert, Inc (10)

More Publishers

Results (242)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of inducible switch promoters that drive exogenous gene expression upon the recognition of CD19 by chimeric antigen receptors
    Meeting Abstract

    Uchibori, R.; Ninomiya, S.; Tsukahara, T.; Ido, H.; Teruya, T.; Omine, K.; Urabe, M.; Mizukami, H.; Kume, A.; Riviere, I.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficient gene correction and engraftment of differently-mobilized human thalassemic CD34+cells
    Meeting Abstract

    Karponi, G.; Papayanni, P.; Lederer, C. W.; Psatha, N.; Zogas, N.; Zervou, F.; Kleanthous, M.; Anagnostopoulos, A.; Sadelain, M.; Riviere, I.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Meeting Abstract

    Brentjens, R.; Davila, M.; Riviere, I.; Wang, X. Y.; Bartido, S.; Park, J.; Bouhassira, D.; Curran, K.; Chung, S.; Stefanski, J.; more...
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I trial of autologous CD19-targeted CAR-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated CLL
    Meeting Abstract

    Park, J. H.; Rivière, I.; Wang, X.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Wasielewska, T.; Taylor, C.; Qu, J.; Bartido, S.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Safe and effective re-induction of complete remissions in adults with relapsed B-ALL using 19-28z CAR CD19-targeted T cell therapy
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Stefanski, J.; He, Q.; Borquez-Ojeda, O.; Taylor, C.; Wasielewska, T.; Qu, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • First US phase I clinical trial of globin gene transfer for the treatment of beta-thalassemia major
    Meeting Abstract

    Boulad, F.; Riviere, I.; Wang, X.; Bartido, S.; Prockop, S. E.; Barone, R.; Moi, P.; Maggio, A.; Sadelain, M.
    Blood (2013)

    Fulltext@MSK | Save